Profound Medical Corp 6-K, filed May 21, 2021
Profound Medical Corp. (PROF)
About this 6-K
Profound Medical Corp filed this 6-K on May 21, 2021.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2021
Commission File Number: 001-39032
PROFOUND MEDICAL CORP.
(Translation of the registrant’s name into English)
2400 Skymark Avenue, Unit 6, Mississauga, Ontario L4W 5K5
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☐ Form 40-F ☒
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
Exhibit 99.1 of this Form 6-K is incorporated by reference into Profound Medical Corp.’s registration statement on Form F-10 (File No. 333-233997).
EXHIBIT INDEX
The following documents, each of which is attached as an exhibit hereto, and is incorporated by reference herein:
|
Exhibit |
Title | |
| 99.1 | Report of Voting Results | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| PROFOUND MEDICAL CORP. | ||||||
| Date: May 21, 2021 | By: |
/s/ Rashed Dewan | ||||
| Name: Rashed Dewan | ||||||
| Title: VP Finance, Manufacturing & Service | ||||||
Exhibit 99.1
PROFOUND MEDICAL CORP.
Report of Voting Results
Pursuant to Section 11.3 of
National Instrument 51-102 – Continuous Disclosure Obligations
The following matters were voted on at the annual meeting of holders of common shares of Profound Medical Corp. (the “Corporation”) held on May 19, 2021 (the “Meeting”). The following sets forth a brief description of each matter that was voted upon at the Meeting and the outcome of the vote.
| 1. | Appointment of Auditors |
By resolution passed by show of hands, PricewaterhouseCoopers LLP was appointed as the auditor of the Corporation to hold office until the close of the next annual meeting or until its successor is duly appointed, at such remuneration as may be determined by the board of directors. The numbers in respect of the vote are based on the proxies received.
| Votes For | % For | Votes Withheld | % Withheld |
| 11,571,097 | 97.976% | 238,990 | 2.024% |
| 2. | Election of Directors |
By resolution passed by show of hands, the following seven (7) nominees were elected as directors of the Corporation. The numbers in respect of the vote are based on the proxies received.
| Nominee | For | % For | Withheld | % Withheld |
| Arun Menawat | 7,193,875 | 98.447% | 113,480 | 1.553% |
| Brian Ellacott | 7,299,341 | 99.890% | 8,014 | 0.110% |
| Kenneth Galbraith | 7,221,571 | 98.826% | 85,784 | 1.174% |
| Cynthia Lavoie | 7,300,445 | 99.905% | 6,910 | 0.095% |
| Murielle Lortie | 7,300,445 | 99.905% | 6,910 | 0.095% |
| Jean-François Pariseau | 7,141,146 | 97.725% | 166,209 | 2.275% |
| Arthur Rosenthal | 7,155,198 | 97.918% | 152,157 | 2.082% |
Toronto, Ontario, May 19, 2021.
| PROFOUND MEDICAL CORP. | |||
| By: | signed “Rashed Dewan” | ||
| Name: | Rashed Dewan | ||
| Title: | VP Finance, Manufacturing & Service | ||